< Back to latest news & events

Brexit

Video: No-Deal Brexit Scenario Planning for Intellectual Property

October 2019

With Brexit deadline approaching, HGF Partner Dr Chris Moore is speaking in Greater Birmingham Chambers of Commerce video about what impact a no-deal Brexit may have on Intellectual Property, including patents, trade marks, copyright and registered designs.

The government maintains that the UK will leave the European Union on 31st October – with or without a deal. In this video, Dr Chris Moore looks at a no-deal Brexit and covers the following:

  • What will change for businesses in a no-deal Brexit scenario
  • Advice for businesses on preparing for a no-deal Brexit scenario
  • What can businesses do now to prepare for Brexit.

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article